424B2
File 333-234586
FORM 424B2
- Filing date
- 03 Aug 2020
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
ASTRAZENECA PLC reports
- Company location
- Cambridge
- Fiscal year end
- 31 December
Company
Names, identifiers, and filing context for this profile.
1 identity field
SEC filing record 1 source field available
ASTRAZENECA PLC has filed 2,050 SEC EDGAR filings since 13 Mar 1995
SEC filing history
Showing 826-850 of 1,000 matching filings.
Per page
25
Current page
34
6-K/A
File 001-11960
6-K/A
- Filing date
- 31 Jul 2020
- Reporting date
- 30 Jun 2020
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
6-K
File 001-11960
AZN: H1 2020 RESULTS
- Filing date
- 30 Jul 2020
- Reporting date
- 30 Jul 2020
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
TAGRISSO US BTD FOR EGFRM ADJUVANT LUNG CANCER
- Filing date
- 30 Jul 2020
- Reporting date
- 30 Jul 2020
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
BOARD COMMITTEE CHANGES
- Filing date
- 29 Jul 2020
- Reporting date
- 29 Jul 2020
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
FARXIGA DAPA-CKD TRIAL MET ALL ENDPOINTS
- Filing date
- 28 Jul 2020
- Reporting date
- 28 Jul 2020
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
IMFINZI RECOMMENDED FOR EU APPROVAL IN SCLC
- Filing date
- 27 Jul 2020
- Reporting date
- 27 Jul 2020
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
CALQUENCE RECEIVES POSITIVE CHMP OPINION FOR CLL
- Filing date
- 27 Jul 2020
- Reporting date
- 27 Jul 2020
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
ASTRAZENECA ENTERS COLLABORATION IN ONCOLOGY
- Filing date
- 27 Jul 2020
- Reporting date
- 27 Jul 2020
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
BREZTRI AEROSPHERE APPROVED IN THE US FOR THE MAINTENANCE TREATMENT OF COPD
- Filing date
- 24 Jul 2020
- Reporting date
- 24 Jul 2020
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
HOLDING(S) IN COMPANY
- Filing date
- 22 Jul 2020
- Reporting date
- 22 Jul 2020
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
HOLDING(S) IN COMPANY
- Filing date
- 22 Jul 2020
- Reporting date
- 22 Jul 2020
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
HOLDING(S) IN COMPANY
- Filing date
- 21 Jul 2020
- Reporting date
- 21 Jul 2020
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
HOLDING(S) IN COMPANY
- Filing date
- 21 Jul 2020
- Reporting date
- 21 Jul 2020
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
COVID-19 VACCINE AZD1222 SHOWED ROBUST IMMUNE RESPONSES IN ALL PARTICIPANTS IN P
- Filing date
- 20 Jul 2020
- Reporting date
- 20 Jul 2020
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
DIRECTOR DECLARATION
- Filing date
- 16 Jul 2020
- Reporting date
- 16 Jul 2020
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
BRILINTA GRANTED US FDA PRIORITY REVIEW FOR STROKE
- Filing date
- 09 Jul 2020
- Reporting date
- 09 Jul 2020
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
LYNPARZA APPROVED IN THE EU FOR BRCA- MUTATED METASTATIC PANCREATIC CANCER
- Filing date
- 08 Jul 2020
- Reporting date
- 08 Jul 2020
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
TOTAL VOTING RIGHTS
- Filing date
- 01 Jul 2020
- Reporting date
- 01 Jul 2020
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 30 Jun 2020
- Reporting date
- 30 Jun 2020
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
SELUMETINIB GRANTED ORPHAN DRUG DESIGNATION IN JAPAN FOR NEUROFIBROMATOSIS TYPE
- Filing date
- 30 Jun 2020
- Reporting date
- 30 Jun 2020
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
11-K
File 001-11960
11-K filing
- Filing date
- 26 Jun 2020
- Reporting date
- 31 Dec 2019
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
HOLDING(S) IN COMPANY
- Filing date
- 17 Jun 2020
- Reporting date
- 17 Jun 2020
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
HOLDING(S) IN COMPANY
- Filing date
- 17 Jun 2020
- Reporting date
- 17 Jun 2020
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-11960
ASTRAZENECA TO SUPPLY EUROPE WITH UP TO 400 MILLION DOSES OF OXFORD UNIVERSITY'S
- Filing date
- 15 Jun 2020
- Reporting date
- 15 Jun 2020
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing